94 related articles for article (PubMed ID: 1614112)
1. [Effect of naftidrofuryl (Praxilene) in primary open angle glaucoma: prospective double-blind study].
Beati D; Mermoud A; Faggioni R
Klin Monbl Augenheilkd; 1992 May; 200(5):407-8. PubMed ID: 1614112
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of normal pressure glaucoma with a serotonin S2 receptor antagonist, naftidrofuryl (praxilen)].
Mermoud A; Faggioni R
Klin Monbl Augenheilkd; 1991 May; 198(5):332-4. PubMed ID: 1886349
[TBL] [Abstract][Full Text] [Related]
3. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.
Quaranta L; Bettelli S; Uva MG; Semeraro F; Turano R; Gandolfo E
Ophthalmology; 2003 Feb; 110(2):359-62; discussion 362-4. PubMed ID: 12578781
[TBL] [Abstract][Full Text] [Related]
4. Double-blind study in the treatment of normal tension glaucoma with naftidrofuryl.
Mermoud A; Faggioni R; Van Melle GD
Ophthalmologica; 1990; 201(3):145-51. PubMed ID: 2089356
[TBL] [Abstract][Full Text] [Related]
5. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
Martínez A; Sánchez M
Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
[TBL] [Abstract][Full Text] [Related]
6. A placebo-controlled 3-year study of a calcium blocker on visual field and ocular circulation in glaucoma with low-normal pressure.
Koseki N; Araie M; Tomidokoro A; Nagahara M; Hasegawa T; Tamaki Y; Yamamoto S
Ophthalmology; 2008 Nov; 115(11):2049-57. PubMed ID: 18672290
[TBL] [Abstract][Full Text] [Related]
7. [Effect of naftidrofuryl (praxilene) on optic nerve head blood flow in the patient with glaucoma].
Achache F; Titzé P; Movaffaghy A; Mermoud A
Klin Monbl Augenheilkd; 1999 May; 214(5):260-2. PubMed ID: 10420359
[TBL] [Abstract][Full Text] [Related]
8. The Low-pressure Glaucoma Treatment Study (LoGTS) study design and baseline characteristics of enrolled patients.
Krupin T; Liebmann JM; Greenfield DS; Rosenberg LF; Ritch R; Yang JW;
Ophthalmology; 2005 Mar; 112(3):376-85. PubMed ID: 15745762
[TBL] [Abstract][Full Text] [Related]
9. Results of the European Glaucoma Prevention Study.
Miglior S; Zeyen T; Pfeiffer N; Cunha-Vaz J; Torri V; Adamsons I;
Ophthalmology; 2005 Mar; 112(3):366-75. PubMed ID: 15745761
[TBL] [Abstract][Full Text] [Related]
10. The effect of nimodipine, a centrally active calcium antagonist, on visual function and mascular blood flow in patients with normal-tension glaucoma and control subjects.
Piltz JR; Bose S; Lanchoney D
J Glaucoma; 1998 Oct; 7(5):336-42. PubMed ID: 9786563
[TBL] [Abstract][Full Text] [Related]
11. The singapore 5-Fluorouracil trabeculectomy study: effects on intraocular pressure control and disease progression at 3 years.
Wong TT; Khaw PT; Aung T; Foster PJ; Htoon HM; Oen FT; Gazzard G; Husain R; Devereux JG; Minassian D; Tan SB; Chew PT; Seah SK
Ophthalmology; 2009 Feb; 116(2):175-84. PubMed ID: 19187822
[TBL] [Abstract][Full Text] [Related]
12. Relationship of progression of visual field damage to postural changes in intraocular pressure in patients with normal-tension glaucoma.
Kiuchi T; Motoyama Y; Oshika T
Ophthalmology; 2006 Dec; 113(12):2150-5. PubMed ID: 16996611
[TBL] [Abstract][Full Text] [Related]
13. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study.
Caprioli J; Coleman AL
Ophthalmology; 2008 Jul; 115(7):1123-1129.e3. PubMed ID: 18082889
[TBL] [Abstract][Full Text] [Related]
14. 24-hour intraocular pressures with brimonidine purite versus dorzolamide added to latanoprost in primary open-angle glaucoma subjects.
Konstas AG; Karabatsas CH; Lallos N; Georgiadis N; Kotsimpou A; Stewart JA; Stewart WC
Ophthalmology; 2005 Apr; 112(4):603-8. PubMed ID: 15808251
[TBL] [Abstract][Full Text] [Related]
15. Effects of oral brovincamine on visual field damage in patients with normal-tension glaucoma with low-normal intraocular pressure.
Koseki N; Araie M; Yamagami J; Shirato S; Yamamoto S
J Glaucoma; 1999 Apr; 8(2):117-23. PubMed ID: 10209728
[TBL] [Abstract][Full Text] [Related]
16. Clinical presentation and initial treatment patterns in patients with exfoliation glaucoma versus primary open-angle glaucoma.
Konstas AG; Stewart WC; Stroman GA; Sine CS
Ophthalmic Surg Lasers; 1997 Feb; 28(2):111-7. PubMed ID: 9054481
[TBL] [Abstract][Full Text] [Related]
17. Glaucoma in a rural population of southern India: the Aravind comprehensive eye survey.
Ramakrishnan R; Nirmalan PK; Krishnadas R; Thulasiraj RD; Tielsch JM; Katz J; Friedman DS; Robin AL
Ophthalmology; 2003 Aug; 110(8):1484-90. PubMed ID: 12917161
[TBL] [Abstract][Full Text] [Related]
18. Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost.
Tamer C; Oksüz H
Ophthalmic Res; 2007; 39(1):24-31. PubMed ID: 17164574
[TBL] [Abstract][Full Text] [Related]
19. Topical and oral ketorolac administration increases the intraocular pressure-lowering effect of latanoprost.
Costagliola C; Campa C; Perri P; Parmeggiani F; Romano MR; Incorvaia C
Curr Eye Res; 2008 May; 33(5):477-82. PubMed ID: 18568885
[TBL] [Abstract][Full Text] [Related]
20. Predictive factors for progressive optic nerve damage in various types of chronic open-angle glaucoma.
Martus P; Stroux A; Budde WM; Mardin CY; Korth M; Jonas JB
Am J Ophthalmol; 2005 Jun; 139(6):999-1009. PubMed ID: 15953429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
